The Noradrenaline Metabolite MHPG Is a Candidate Biomarker from the Manic to the Remission State in Bipolar Disorder I: A Clinical Naturalistic Study

• Masatake Kurita ,

  * E-mail: kurita@koutoku.or.jp

  Affiliations Sato Hospital, Koutokukai, 948-1 Kunugizuka, Nanyo, Yamagata, Japan, Department of Cellular Signaling, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai, Japan, Department of Psychiatry and Behavioral Science, Graduate School of Medicine, Nippon Medical School, Bunkyo-ku, Tokyo, Japan

  ⨯
• Satoshi Nishino,

  Affiliations Sato Hospital, Koutokukai, 948-1 Kunugizuka, Nanyo, Yamagata, Japan, Department of Cellular Signaling, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai, Japan

  ⨯
• Yukio Numata,

  Affiliation Sato Hospital, Koutokukai, 948-1 Kunugizuka, Nanyo, Yamagata, Japan

  ⨯
• Yoshiro Okubo,

  Affiliation Department of Psychiatry and Behavioral Science, Graduate School of Medicine, Nippon Medical School, Bunkyo-ku, Tokyo, Japan

  ⨯
• Tadahiro Sato

  Affiliation Sato Hospital, Koutokukai, 948-1 Kunugizuka, Nanyo, Yamagata, Japan

  ⨯